根据《金边邮报》官网消息，柬埔寨计划在2025年初引入每2个月注射一次的长效暴露前预防（PrEP）药物卡替拉韦（Cabotegravir），以遏制艾滋感染。 根据柬埔寨 国家艾滋、皮肤病和性病中心主任Ouk ...

You need to have injections every two months to make sure that the drugs maintain high levels in your bloodstream to prevent HIV infection. Cabotegravir is a long-acting form of PrEP, taken by ...

Global leaders must urgently prioritise and work to provide access to new long-acting HIV prevention -- and potentially ...

£35 means we can empower more people living with HIV to challenge stigma with our information workshops, videos and broadcasts. Cabotegravir and rilpivirine are medications used to treat HIV, ...

Comparator companies AAH Pharmaceuticals Ltd (emtricitabine, tenofovir disoproxil) – confidentiality agreement not signed, not participating Accord Healthcare Ltd (emtricitabine, tenofovir disoproxil) ...

The combination of ViiV’s experimental integrase inhibitor cabotegravir and Janssen’s Edurant (rilpivirine), injected every four weeks, could change HIV treatment from 365 dosing days per year ...

UNAIDS urges speed and compassion urging pharmaceutical companies to enable access to new, life-saving medicines DAVOS/GENEVA, 21 January 2025—Today, at the World Economic Forum’s annual meeting in ...

Cabotegravir – given the trade name Apretude – can be dosed just six times a year and showed superior results to daily, oral therapy with Gilead's widely used Truvada (emtricitabine and ...